Emerging virus in raccoons may provide cancer clues

December 12, 2012

Rare brain tumors emerging among raccoons in Northern California and Oregon may be linked to a previously unidentified virus discovered by a team of researchers, led by scientists from the University of California, Davis. Their findings, published today in the journal Emerging Infectious Diseases, could lead to a better understanding of how viruses can cause cancer in animals and humans.

Necropsies conducted since March 2010 by scientists at the UC Davis School of Veterinary Medicine and UC Davis-led California Animal Health and Food Safety Laboratory found brain tumors in 10 raccoons, nine of which were from Northern California, the article reports. The 10th was sent to UC Davis by researchers at Oregon State University in Corvallis, Ore.

The common factor, found in all of the tumors, was a newly described virus, dubbed raccoon polyomavirus. Researchers suspect this virus contributes to tumor formation.

Polyomaviruses, which are prevalent but rarely cause cancer, do not typically cross from one species to another, so the outbreak is not expected to spread to people or other animals.

Two more raccoons with the tumor and the virus have been found in Yolo and Marin counties since September 2012, when the article was submitted to the journal for publication.

"Raccoons hardly ever get tumors," said study author Patricia Pesavento, a pathologist with the UC Davis School of Veterinary Medicine. "That's why we take notice when we get three tumors, much less 12."

Polyomaviruses are known to cause cancer under laboratory conditions. Less is known about their ability to cause cancer under natural conditions among people, because cancer often takes decades to develop.

Raccoons, with their short lifespans of two to three years, can provide a model for studying how these viruses spread outside the laboratory, how they cause cancer, and how easily they can jump from species to species.

Of the 12 raccoons affected, 10 were collected from Marin County. Pesavento said this does not mean the virus is limited to that county, or even to Northern California. Marin County is home to WildCare, an animal rescue and rehabilitation center that routinely submits animal remains for diagnostic testing, which might result in a sampling bias.

Other California raccoons were submitted by Lindsay Wildlife Museum in Contra Costa County and Sonoma Wildlife Rescue. Pesavento said her lab is collecting specimens and data from other sources across the country, looking for the virus and for raccoon exposure to it.

Pesavento said more research is needed to understand whether an environmental toxin, genetics or other explanation is contributing to the cancer. The study said that raccoons are exposed daily to human waste, garbage, environmental toxins and environmental pathogens as they travel along sewer and water lines.

"This is just the beginning of a story," said Pesavento, adding that high rates of cancer among wildlife are found in animals that live in close proximity to humans. "Wildlife live in our fields, our trash cans, our sewer lines, and that's where we dump things. Humans need to be guardians of the wildlife-human interface, and raccoons are important sentinel animals. They really are exquisitely exposed to our waste. We may be contributing to their susceptibility in ways we haven't discovered."

Infectious pathogens, such as viruses, are associated with 15-20 percent of all human cancers worldwide, according to the American Cancer Society. For example, human papillomavirus can lead to cervical cancer. Feline leukemia virus, for which UC Davis developed a vaccine, can cause cancer in cats. UC Davis also continues to study Marek's disease, a deadly virus in chickens that is providing insight into human cancer.

"This work to investigate natural associations of cancer verifies the importance of our One Health approach to addressing complex biomedical problems, such as viral causes of cancer," said Michael Lairmore, dean of the School of Veterinary Medicine, of which the UC Davis One Health Institute is a part. "Understanding how infectious agents may contribute to cancer in animals has provided fundamental new knowledge on the cause of cancer in people."
-end-
The study was funded through The Bernice Barbour Foundation, the UC Davis Center for Companion Animal Health, and Meadowview Foundation.

The study's authors include lead author Florante Dela Cruz, Federico Giannitti and Leslie Woods from UC Davis; Eric Delwart from University of California, San Francisco, and Blood Systems Research Institute in San Francisco; Linlin Li from Blood Systems Research Institute; and Luis Del Valle from Louisiana State University in New Orleans.

About the UC Davis School of Veterinary Medicine

Leading Veterinary Medicine, Addressing Societal Needs: The School of Veterinary Medicine serves the people of California by providing educational, research, clinical service, and public service programs of the highest quality to advance the health and care of animals, the environment, and the public, and to contribute to the economy. For more information, visit www.vetmed.ucdavis.edu.

About UC Davis

For more than 100 years, UC Davis has engaged in teaching, research and public service that matter to California and transform the world. Located close to the state capital, UC Davis has more than 33,000 students, more than 2,500 faculty and more than 21,000 staff, an annual research budget of nearly $750 million, a comprehensive health system and 13 specialized research centers. The university offers interdisciplinary graduate study and more than 100 undergraduate majors in four colleges -- Agricultural and Environmental Sciences, Biological Sciences, Engineering, and Letters and Science. It also houses six professional schools -- Education, Law, Management, Medicine, Veterinary Medicine and the Betty Irene Moore School of Nursing.

University of California - Davis

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.